Physician profile

Ilan E Timor

Maternal & Fetal Medicine · New York, NY

NPI 1073508073

$36,253.56

in general payments reported to CMS, 2019-2025

2 companies · $4,813 in 2025

The $4,813 reported for 2025 was more than what 95% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$24,622.56
Travel and Lodging$9,254.18
Food and Beverage$296.37

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Samsung Hme America, INC. $34,173.11 2023-2025
Ge Healthcare $2,080.45 2021-2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ilan E Timor

$36,253.56

in general payments reported 2019-2025

Years
2021-2025
Top company
Samsung Hme America, INC.
Context
The $4,813 reported for 2025 was more than what 95% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).

https://glasscript.com/doctor/621424/ilan-e-timor

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.